1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar PustulosisSkin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, palmoplantar pustulosis, psoriasis, skin disorderRecruitingPhase 22026-10-01NCT07013201